These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6119763)

  • 1. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora.
    Krook A; Järnerot G; Danielsson D
    Scand J Gastroenterol; 1981; 16(4):569-75. PubMed ID: 6119763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metronidazole and sulfasalazine on the fecal flora in patients with Crohn's disease.
    Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1981; 16(2):183-92. PubMed ID: 6118940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of bacteroides species to metronidazole during treatment of patients with Crohn's disease and healthy individuals.
    Krook A; Kjellander J; Danielsson D
    Scand J Infect Dis; 1982; 14(1):45-8. PubMed ID: 7071526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metronidazole and sulfasalazine on the normal human faecal flora.
    Krook A
    Scand J Gastroenterol; 1981; 16(5):587-92. PubMed ID: 6119764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the fecal flora of patients with Crohn's disease during treatment with metronidazole. A preliminary report.
    Krook A; Danielsson D; Kjellander J; Järnerot G
    Scand J Gastroenterol; 1979; 14(6):705-10. PubMed ID: 231297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations.
    Rosén A; Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O
    Gastroenterology; 1982 Sep; 83(3):541-9. PubMed ID: 6124473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    West B; Lendrum R; Hill MJ; Walker G
    Gut; 1974 Dec; 15(12):960-5. PubMed ID: 4155692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.
    Krook A; Lindström B; Kjellander J; Järnerot G; Bodin L
    J Clin Pathol; 1981 Jun; 34(6):645-50. PubMed ID: 7251906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbial flora of the rectal mucosa and faeces of patients with Crohn's disease before and during antimicrobial chemotherapy.
    Hudson MJ; Hill MJ; Elliott PR; Berghouse LM; Burnham WR; Lennard-Jones JE
    J Med Microbiol; 1984 Dec; 18(3):335-45. PubMed ID: 6334160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment.
    Malchow H; Ewe K; Brandes JW; Goebell H; Ehms H; Sommer H; Jesdinsky H
    Gastroenterology; 1984 Feb; 86(2):249-66. PubMed ID: 6140202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole in Crohn's disease.
    Gilat T
    Gastroenterology; 1982 Sep; 83(3):702-4. PubMed ID: 6124478
    [No Abstract]   [Full Text] [Related]  

  • 13. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole for Crohn's disease.
    Ursing B; Kamme C
    Lancet; 1975 Apr; 1(7910):775-7. PubMed ID: 48003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Crohn's disease with metronidazole (author's transl)].
    Schneider MU; Strobel S; Riemann JF; Demling L
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1126-9. PubMed ID: 6114847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The faecal flora of patients with Crohn's disease.
    Wensinck F; Custers-van Lieshout ; Poppelaars-Kustermans PA; Schröder AM
    J Hyg (Lond); 1981 Aug; 87(1):1-12. PubMed ID: 7019315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R; Walker JG; West B; Hill MJ
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum concentrations of metronidazole and its main metabolite in patients with active Crohn's disease: correlation with disease activity and therapeutic efficacy?
    Schneider MU; Riemann JF; Laudage G
    Chemotherapy; 1984; 30(6):345-52. PubMed ID: 6518833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronidazole exhibits no clastogenic activity in a double-blind cross-over study on Crohn's patients.
    Mitelman F; Strömbeck B; Ursing B; Nordle O; Hartley-Asp B
    Hereditas; 1982; 96(2):279-86. PubMed ID: 6125490
    [No Abstract]   [Full Text] [Related]  

  • 20. [7 clinics evaluate metronidazole therapy in Crohn's disease].
    Lakartidningen; 1976 Nov; 73(48):4196-7. PubMed ID: 11371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.